Compare CAKE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | VERA |
|---|---|---|
| Founded | 1972 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 1996 | 2021 |
| Metric | CAKE | VERA |
|---|---|---|
| Price | $57.60 | $39.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $59.47 | ★ $81.30 |
| AVG Volume (30 Days) | ★ 1.4M | 968.6K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.06 | N/A |
| Revenue | ★ $3,751,806,000.00 | N/A |
| Revenue This Year | $6.16 | N/A |
| Revenue Next Year | $6.60 | $445.28 |
| P/E Ratio | $18.52 | ★ N/A |
| Revenue Growth | ★ 4.75 | N/A |
| 52 Week Low | $43.00 | $18.53 |
| 52 Week High | $69.70 | $56.05 |
| Indicator | CAKE | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 38.93 | 42.61 |
| Support Level | $57.03 | $19.84 |
| Resistance Level | $64.18 | $56.05 |
| Average True Range (ATR) | 2.18 | 2.29 |
| MACD | -0.97 | 0.16 |
| Stochastic Oscillator | 9.90 | 39.02 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.